Ketoconazole Prices, Trend 2026: Index, Demand, Chart and Forecast

According to ChemAnalyst, The Ketoconazole Prices recorded mixed regional dynamics during the second quarter of 2026, with North America and APAC experiencing upward price pressure while Europe remained comparatively stable. Changes in production costs, pharmaceutical demand, inflation, energy expenses, retail activity, and industrial performance shaped the global pricing environment for Ketoconazole during the quarter ending June 2026.

Ketoconazole is a synthetic imidazole antifungal compound widely used in pharmaceutical formulations, particularly topical creams, shampoos, and other treatments for fungal and yeast infections. Because its manufacturing process depends on pharmaceutical-grade intermediates, solvents, energy, quality-control processes, and specialized production facilities, changes in input costs can have a noticeable impact on market pricing.

During Q2 2026, rising producer prices were an important bullish factor in North America and APAC. Meanwhile, softer demand indicators in China and weak industrial sentiment in Germany limited the potential for stronger price increases in those markets.

Overall, Ketoconazole Prices in Q2 2026 reflected a market balancing higher manufacturing expenses against region-specific demand conditions and changing macroeconomic fundamentals.

Ketoconazole Prices in North America

In the United States, the Ketoconazole Price Index increased quarter-over-quarter in Q2 2026, primarily because of higher production costs. Pharmaceutical manufacturers and suppliers faced elevated expenses associated with manufacturing, energy, logistics, and other operating inputs.

One of the strongest cost-side indicators was the US Producer Price Index (PPI), which increased 5.5% year-over-year in June 2026. The rise in producer prices indicated significant cost pressure across the industrial economy and contributed to higher expenses associated with Ketoconazole manufacturing and downstream pharmaceutical production.

Demand conditions also provided support to the market. US retail sales increased 6.9% year-over-year in May 2026, indicating relatively strong consumer spending. This environment supported demand for healthcare and OTC pharmaceutical products, including topical antifungal formulations containing Ketoconazole.

The pharmaceutical and healthcare sectors also strengthened during Q2, helping maintain demand for pharmaceutical active ingredients. Stable healthcare consumption provided a degree of insulation against weaker conditions in other areas of the economy.

However, inflation remained an important consideration. US consumer prices increased 3.5% year-over-year in June 2026, putting pressure on household purchasing power. Although essential healthcare products tend to demonstrate relatively resilient demand, persistent inflation can affect discretionary spending and increase operating expenses throughout the pharmaceutical supply chain.

Higher and volatile crude oil prices during much of Q2 also contributed to increased energy, freight, and transportation costs. These factors added to the landed cost of pharmaceutical raw materials and finished products.

Get Real Time Online for Ketoconazole Prices: https://www.chemanalyst.com/Pricing-data/ketoconazole-1508

At the same time, US industrial production increased only 0.7% year-over-year in June 2026, suggesting that the broader manufacturing environment remained relatively slow. Nevertheless, the labor market remained supportive, with unemployment at 4.2% in June 2026, helping sustain income levels and consumer purchasing power.

Why Did Ketoconazole Prices Change in June 2026 in North America?

The principal factors influencing Ketoconazole Prices in North America during June included:

• Higher production costs: The 5.5% year-over-year increase in US PPI raised manufacturing expenses.
• Strong consumer demand: Retail sales increased 6.9% year-over-year in May, supporting OTC and healthcare product consumption.
• Inflation: CPI increased 3.5% year-over-year in June, raising operating and consumer costs.
• Energy and logistics: Crude oil volatility increased transportation and energy expenses.
• Moderate industrial growth: Industrial production grew only 0.7% year-over-year, limiting broader industrial momentum.

Consequently, the balance of higher costs and resilient healthcare demand resulted in a firm Ketoconazole Price Index in the United States during Q2 2026.

Ketoconazole Prices in APAC

The APAC market also experienced upward price movement during Q2 2026. In China, the Ketoconazole Price Index rose quarter-over-quarter, primarily due to increasing production costs.

Ketoconazole prices were assessed at approximately USD 72,000/MT FOB India, reflecting the elevated value of pharmaceutical-grade material in the regional market.

China's PPI increased 4.1% year-over-year in June 2026, demonstrating continued producer-side cost pressure. Higher expenses for manufacturing inputs and industrial operations contributed to an increase in the cost base for Ketoconazole producers.

However, demand conditions were less supportive than those observed in North America. China's domestic retail sales grew only 1.0% year-over-year in June 2026, indicating relatively subdued consumer demand. This restricted the extent to which producers could pass higher production expenses through to customers.

Industrial activity provided a counterbalancing factor. China's industrial production increased 5.3% year-over-year in June 2026, while the Manufacturing Index expanded during the month. Strong industrial activity supported the availability of chemicals and pharmaceutical manufacturing inputs, preventing supply-side constraints from becoming excessively severe.

Currency movements also influenced pricing. A firmer Chinese yuan modestly increased the cost of imported feedstock inputs when translated into local production economics, contributing to higher manufacturing expenses for producers dependent on imported materials.

Oil prices declined sharply from April and stabilized at lower levels toward the end of Q2. This helped moderate energy and transportation expenses and partially offset the pressure created by higher producer prices.

Consumer inflation remained relatively contained in China, with CPI increasing only 1.0% year-over-year in June 2026. This helped preserve consumer purchasing power, although the limited retail-sales growth indicated that demand remained relatively cautious.

The labor market was also comparatively stable, with unemployment at 5.0% in June 2026. While stable employment provided an underlying foundation for consumption, the indicator did not generate strong bullish pressure for Ketoconazole demand.

Why Did Ketoconazole Prices Change in June 2026 in APAC?

The key factors affecting Ketoconazole Prices in APAC were:

• Rising production costs: China's PPI rose 4.1% year-over-year in June.
• Moderate domestic demand: Retail sales increased only 1.0%, limiting demand-driven price gains.
• Currency effects: A firmer yuan increased the cost of imported feedstock inputs.
• Strong industrial activity: Industrial production grew 5.3%, supporting manufacturing and supply.
• Lower oil prices: Declining crude prices moderated energy and logistics costs.

Therefore, the APAC market experienced upward price movement, but weaker domestic demand and lower energy costs prevented a sharper increase.

Ketoconazole Prices in Europe

European Ketoconazole Prices remained comparatively stable during Q2 2026. In Germany, the Price Index showed limited movement as higher production costs were broadly balanced by moderate demand and softer industrial conditions.

German producer prices for industrial products increased 2.2% year-over-year in May 2026, indicating that manufacturers continued to face cost inflation. These higher costs placed upward pressure on pharmaceutical manufacturing expenses and consequently supported the Ketoconazole market.

Demand was relatively supportive, particularly for OTC pharmaceutical products. German retail sales increased 1.8% year-over-year in May 2026, indicating continued consumer spending and providing some support for topical Ketoconazole products.

However, the broader industrial environment remained challenging. German industrial production was unchanged at 0.0% year-over-year in May 2026, indicating limited manufacturing expansion. Industrial confidence also contracted in June, creating uncertainty around future production activity and pharmaceutical supply-chain conditions.

Energy prices experienced a slight decline in June, providing some relief to chemical and pharmaceutical manufacturers. Lower energy expenses helped offset part of the increase in producer prices.

Consumer inflation stood at 2.3% year-over-year in June 2026, influencing purchasing power and pharmaceutical consumption. Healthcare products generally remain more resilient than discretionary goods, but persistent inflation can still affect household spending patterns.

Germany's unemployment rate remained stable at 3.8% in May 2026, providing a relatively solid labor-market foundation. Nevertheless, negative consumer confidence in June limited the overall bullish impact of employment stability.

Why Did Ketoconazole Prices Change in June 2026 in Europe?

The main factors shaping European Ketoconazole Prices included:

• Producer-price inflation: Industrial producer prices increased 2.2% year-over-year in May.
• Retail demand: Retail sales grew 1.8%, supporting OTC Ketoconazole consumption.
• Weak industrial production: Industrial production remained unchanged year-over-year.
• Lower energy costs: Slightly declining energy prices helped pharmaceutical manufacturers.
• Weak industrial confidence: Contracting confidence created uncertainty around production and supply-chain activity.
• Moderate inflation: CPI increased 2.3% year-over-year in June.

These factors resulted in a relatively balanced European market, keeping the Ketoconazole Price Index broadly stable during Q2 2026.

Global Factors Influencing Ketoconazole Prices in Q2 2026

Several common factors influenced Ketoconazole pricing across regions during the quarter.

Production Costs

Production expenses were the strongest bullish factor in North America and APAC. Rising producer prices increased the cost of pharmaceutical manufacturing inputs, utilities, labor, packaging, and related services.

Pharmaceutical Demand

Healthcare consumption remained an important source of demand stability. Ketoconazole is used in formulations for treating fungal infections, meaning pharmaceutical demand can remain relatively resilient even when discretionary consumer spending weakens.

Crude Oil and Energy

Oil prices had contrasting regional effects. Higher and volatile crude prices in North America increased transportation and energy expenses, while declining oil prices toward the end of Q2 provided cost relief in APAC and Europe.

Inflation and Consumer Spending

Inflation affected both manufacturers and consumers. Higher CPI readings can increase manufacturing and distribution expenses while simultaneously reducing purchasing power. Retail sales therefore remained an important indicator for evaluating demand conditions.

Industrial Activity

Industrial production trends influenced the supply side of the market. Stronger manufacturing activity in China supported supply availability, whereas stagnant German industrial production and moderate US growth indicated more limited industrial momentum.

Book A Demo for Ketoconazole Prices: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Ketoconazole

Ketoconazole Price Forecast

The Ketoconazole Price Forecast for the coming period will likely depend on the interaction between pharmaceutical demand, production costs, raw-material availability, energy prices, and global economic conditions.

North American prices may remain firm if elevated producer costs persist and healthcare demand continues to support pharmaceutical consumption. However, slower industrial activity could limit the pace of further increases.

In APAC, price movement may remain closely linked to Chinese production costs and currency conditions. Strong industrial production could support supply, while subdued retail demand may restrict aggressive price increases. Lower energy costs could also provide some relief to producers.

European prices are expected to remain comparatively stable if energy costs remain manageable and pharmaceutical demand stays resilient. However, weak industrial confidence and limited production growth could prevent significant upward price movement.

Conclusion

The Q2 2026 market demonstrated that Ketoconazole Prices were highly sensitive to regional differences in production costs, consumer demand, industrial activity, inflation, and energy markets.

North America recorded upward price movement as higher producer costs and strong retail demand supported the market. APAC also experienced rising prices, although weaker Chinese domestic demand moderated the increase. Europe remained stable as higher production costs were offset by lower energy prices and subdued industrial activity.

Going forward, market participants should closely monitor producer-price inflation, pharmaceutical demand, crude oil prices, currency movements, retail sales, and industrial production. These indicators will remain important for understanding the direction of Ketoconazole Prices, assessing procurement risks, and developing reliable pricing strategies. 

About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

Address:

420 Lexington Avenue, Suite 300 New York, NY 10170 United States

Phone: +1 332 258 6602

Email: sales@chemanalyst.com

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_